对于TP53突变的AML,德西的合成致死性加上ATR抑制
Jeremy T Baeten1, Sumedha Agashe1, Imene Tabet1
1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Blood advances
|January 29, 2026
概括
骨髓瘤瘤中的TP53突变会使预后恶化. 将德平与ATR抑制剂结合起来,通过利用TP53突变急性髓性白血病中德平诱导的复制应激来提供一种新的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- TP53突变发生在10-15%的骨髓瘤中,与不良结果相关.
- 低甲基化剂,如德西他,表现出活性,但很少在TP53-突变骨髓瘤 (TP53-MN) 中实现完全缓解.
- 了解TP53-MN中对低甲基化剂的分子反应对于改善治疗至关重要.
研究的目的:
- 调查TP53-突变骨髓瘤瘤中底层的德西他宾反应的分子机制.
- 为了确定TP53-突变急性髓性白血病 (TP53-AML) 的潜在治疗漏洞.
- 评价将德西与ATR抑制结合作为一种新的治疗策略的疗效.
主要方法:
- 评估了dcitabine对TP53-AML细胞中的DNA复制,DNA断裂和ATR通路激活的影响.
- 研究了将德西与ATR抑制剂 (ATRi) 结合对TP53-AML细胞活性的影响.
- 评估了TP53-AML在体内小鼠模型中的组合疗法.
主要成果:
- 德西塔会诱导复制性压力,DNA断裂和ATR通路激活,这在TP53-AML细胞中解决不良.
- 在TP53-AML中,decitabine和ATRi的组合会选择性地导致合成致死性,部分是通过线粒体灾难.
- 这种协同效应没有观察到阿扎西蒂丁或DNMT1抑制剂.
- 在临床前模型中,联合德平和ATRi治疗减少了白血病负担,改善了临床前模型中的生存率.
结论:
- 在髓状瘤中,TP53的损失会导致特异性的脆弱性,使得desitabine诱导的复制应激产生特殊的脆弱性.
- 与ATR抑制相结合的德平是一种对TP53突变骨髓瘤瘤的有前途的新疗法.
- 针对复制应激解决途径的向可以克服TP53突变AML中对低甲基化剂的耐药性.
相关概念视频
Mutations
94.5K
Overview
94.5K
Mutations
44.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Lethal Alleles
18.0K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
18.0K
Viral Mutations
39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Synthetic Biology
5.6K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
5.6K


